{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:02:47Z","timestamp":1780758167813,"version":"3.54.1"},"reference-count":125,"publisher":"Elsevier","isbn-type":[{"value":"9780443415470","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apha.2026.02.006","type":"book-chapter","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:32:12Z","timestamp":1771936332000},"page":"171-211","source":"Crossref","is-referenced-by-count":0,"title":["Brain delivery of proteins with shuttle peptides"],"prefix":"10.1016","author":[{"given":"Alejandro","family":"Ben\u00edtez-Troncoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"S\u00e1nchez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Plaza-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.apha.2026.02.006_bib1","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions","volume":"2","author":"Aarts","year":"2002","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-3549(15)00188-4","article-title":"Comparison of linear and cyclic his-ala-val peptides in modulating the blood-brain barrier permeability: Impact on delivery of molecules to the brain","volume":"105","author":"Alaofi","year":"2016","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.apha.2026.02.006_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.apha.2026.02.006_bib5","article-title":"Therapeutic effect of transmembrane TAT-tCNTF via Erk and Akt activation using in vitro and in vivo models of Alzheimer\u2019s disease","volume":"11","author":"Bi","year":"2018","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/bs.apha.2026.02.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(00)00139-3","article-title":"Delivery of peptides and proteins through the blood-brain q barrier","volume":"46","author":"Bickel","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib7","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/jcmm.13365","article-title":"Frataxin-deficient neurons and mice models of Friedreich ataxia are improved by TAT-MTScs-FXN treatment","volume":"22","author":"Britti","year":"2018","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"13","key":"10.1016\/bs.apha.2026.02.006_bib9","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1523\/JNEUROSCI.22-13-05423.2002","article-title":"In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis","volume":"22","author":"Cao","year":"2002","journal-title":"Journal of Neuroscience"},{"issue":"13","key":"10.1016\/bs.apha.2026.02.006_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2174\/1381612826666200213094556","article-title":"D PepH3, an improved peptide shuttle for receptor-independent transport across the blood-brain barrier","volume":"26","author":"Cavaco","year":"2020","journal-title":"Current Pharmaceutical Design"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030672","article-title":"Strategies for targeted delivery of exosomes to the brain: Advantages and challenges","volume":"14","author":"Choi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.addr.2003.12.003","article-title":"Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake","volume":"56","author":"Chung","year":"2004","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/acn3.51971","article-title":"Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI-1601) in Friedreich\u2019s ataxia","volume":"11","author":"Clayton","year":"2024","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.006_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013741","article-title":"The mouse blood-brain barrier transcriptome: A new resource for understanding the development and function of brain endothelial cells","volume":"5","author":"Daneman","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191052","article-title":"Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos","volume":"13","author":"David","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12248-025-01093-y","article-title":"Pharmacokinetics and pharmacodynamics of nomlabofusp in non-clinical studies of Friedreich\u2019s Ataxia","volume":"27","author":"De Toni","year":"2025","journal-title":"The AAPS Journal"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.006_bib17","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.138.4.877","article-title":"A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier","volume":"138","author":"Dehouck","year":"1997","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.107.131318","article-title":"Identification and design of peptides as a new drug delivery system for the brain","volume":"324","author":"Demeule","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib19","doi-asserted-by":"crossref","unstructured":"Derossit, D., Joliott, M.H., Chassaingl, G., & Prochiantztn, M. (1994). THE JDWRXAL OF BioLoCteAL cheimmtry the third helix of the antennapedia homeodornain translocates through biological \u223c embranes \u223c (Vol. 269, Issue 14).","DOI":"10.1016\/S0021-9258(17)34080-2"},{"key":"10.1016\/bs.apha.2026.02.006_bib20","series-title":"Advanced in Pharmacology: Brain Peptide Shuttles","article-title":"Chemically enhanced brain shuttle peptides","volume":"Vol. 105","author":"D\u00edaz","year":"2025"},{"issue":"44","key":"10.1016\/bs.apha.2026.02.006_bib21","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1039\/C8SC02415D","article-title":"Branched BBB-shuttle peptides: Chemoselective modification of proteins to enhance blood-brain barrier transport","volume":"9","author":"D\u00edaz-Perlas","year":"2018","journal-title":"Chemical Science"},{"key":"10.1016\/bs.apha.2026.02.006_bib22","series-title":"Topics in current chemistry","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-29686-9_4","article-title":"Strain-promoted 1,3-Dipolar cycloaddition of cycloalkynes and organic azides","author":"Dommerholt","year":"2016"},{"key":"10.1016\/bs.apha.2026.02.006_bib23","first-page":"203","article-title":"Delivery of chemotherapeutics across the blood-brain barrier: Challenges and advances","volume":"vol. 71","author":"Doolittle","year":"2014"},{"key":"10.1016\/bs.apha.2026.02.006_bib24","doi-asserted-by":"crossref","unstructured":"Dyer, C. A. & Curtis, L. K. (1991). A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor\u204e. 8. https:\/\/doi.org\/10.1016\/S0021-9258(18)54425\u20132.","DOI":"10.1016\/S0021-9258(18)54425-2"},{"issue":"9\u201310","key":"10.1016\/bs.apha.2026.02.006_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/ten.tea.2015.0471","article-title":"Local delivery of neurotrophin-3 and anti-NogoA promotes repair after spinal cord injury","volume":"22","author":"Elliott Donaghue","year":"2016","journal-title":"Tissue Engineering - Part A"},{"key":"10.1016\/bs.apha.2026.02.006_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biochi.2018.10.010","article-title":"Neuroprotective effects of Tat-ATOX1 protein against MPP+-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson\u2019s disease","volume":"156","author":"Eum","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/bs.apha.2026.02.006_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-mediated transcytosis of transferrin across the blood-brain barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/bs.apha.2026.02.006_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"Journal of Controlled Release"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.006_bib29","doi-asserted-by":"crossref","DOI":"10.2337\/diab.34.8.728","article-title":"Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits","volume":"34","author":"Frank","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/bs.apha.2026.02.006_bib30","first-page":"38","article-title":"Antibody therapies in CNS diseases","volume":"vol. 12","author":"Freskg\u00e5rd","year":"2017"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020092","article-title":"Monoclonal antibodies as neurological therapeutics","volume":"14","author":"Gklinos","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"56","key":"10.1016\/bs.apha.2026.02.006_bib32","doi-asserted-by":"crossref","DOI":"10.3791\/2968","article-title":"Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice","author":"Glascock","year":"2011","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/bs.apha.2026.02.006_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"Journal of Controlled Release"},{"issue":"24","key":"10.1016\/bs.apha.2026.02.006_bib34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Hartmuth","year":"2003","journal-title":"Drug Discovery Today"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS Journal"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib36","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/ijms14022862","article-title":"In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery","volume":"14","author":"Huang","year":"2013","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-019-0869-3","article-title":"Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood\u2013brain barrier and target glioma","volume":"9","author":"Ji","year":"2019","journal-title":"AMB Express"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.006_bib38","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.8b05265","article-title":"Apolipoprotein e peptide-directed chimeric polymersomes mediate an ultrahigh-efficiency targeted protein therapy for glioblastoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib39","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-007-9379-0","article-title":"Blood-brain barrier transport of therapeutics via receptor-mediation","volume":"24","author":"Jones","year":"2007","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/ejn.14974","article-title":"Heparan sulfate proteoglycan-mediated dynamin-dependent transport of neural stem cell exosomes in an in vitro blood\u2013brain barrier model","volume":"53","author":"Joshi","year":"2021","journal-title":"European Journal of Neuroscience"},{"issue":"19","key":"10.1016\/bs.apha.2026.02.006_bib41","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-10-0987","article-title":"Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer","volume":"16","author":"Junutula","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.apha.2026.02.006_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002469","article-title":"A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier","volume":"3","author":"Karkan","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.006_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1527-3458.2005.tb00054.x","article-title":"TAT-GDNF in neurodegeneration and ischemic stroke","volume":"11","author":"Kilic","year":"2005","journal-title":"CNS Drug Reviews"},{"issue":"4","key":"10.1016\/bs.apha.2026.02.006_bib45","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbrc.2005.12.112","article-title":"Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound","volume":"340","author":"Kinoshita","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2026.02.006_bib46","unstructured":"Kinoshita, M., Mcdannold, N., Jolesz, F.A., & Hynynen, K. (2006). Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. http:\/\/www.pnas.orgcgidoi10.1073pnas.0604318103."},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/mp100293m","article-title":"Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides","volume":"8","author":"Kiptoo","year":"2011","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib48","doi-asserted-by":"crossref","unstructured":"Kumagais, A.K., Eisenberg, J.B., & Pardridges, W.M. (1987). Absorptive-mediated Endocytosis of Cationized Albumin and a P-Endorphin-cationized Albumin Chimeric Peptide by Isolated Brain Capillaries\u204e (Vol. 262, Issue 31).","DOI":"10.1016\/S0021-9258(18)48160-4"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jps.24309","article-title":"Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability","volume":"104","author":"Laksitorini","year":"2015","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.006_bib50","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1432-1327.2001.02073.x","article-title":"Receptor mediated uptake of peptides that bind the human transferrin receptor","volume":"268","author":"Lee","year":"2001","journal-title":"European Journal of Biochemistry"},{"issue":"48","key":"10.1016\/bs.apha.2026.02.006_bib51","doi-asserted-by":"crossref","first-page":"79401","DOI":"10.18632\/oncotarget.12708","article-title":"Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06544.x","article-title":"Macromolecular drug transport into the brain using targeted therapy","volume":"113","author":"Lichota","year":"2010","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/D3CB00194F","article-title":"BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium","volume":"5","author":"Lucana","year":"2023","journal-title":"RSC Chemical Biology"},{"key":"10.1016\/bs.apha.2026.02.006_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","article-title":"Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting","volume":"282","author":"Mart\u00ednez-Jothar","year":"2018","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib55","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/acs.molpharmaceut.4c01091","article-title":"A site-specific miniAp4-trastuzumab conjugate prevents brain metastasis","volume":"22","author":"Masmudi-Mart\u00edn","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"12\u201313","key":"10.1016\/bs.apha.2026.02.006_bib56","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/marc.200800159","article-title":"Polymer \u201cclicking\u201d by CuAAC reactions","volume":"29","author":"Meldal","year":"2008","journal-title":"Macromolecular Rapid Communications"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib57","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/mt.2013.267","article-title":"Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain","volume":"22","author":"Meng","year":"2014","journal-title":"Molecular Therapy"},{"issue":"7","key":"10.1016\/bs.apha.2026.02.006_bib58","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ymthe.2017.03.037","article-title":"A basic ApoE-based peptide mediator to deliver proteins across the blood-brain barrier: Long-term efficacy, toxicity, and mechanism","volume":"25","author":"Meng","year":"2017","journal-title":"Molecular Therapy"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib59","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1096\/fj.201600827R","article-title":"Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier","volume":"31","author":"Molino","year":"2017","journal-title":"FASEB Journal"},{"issue":"24","key":"10.1016\/bs.apha.2026.02.006_bib60","article-title":"Low-level endothelial trail-receptor expression obstructs the cns-delivery of angiopep-2 functionalised trail-receptor agonists for the treatment of glioblastoma","volume":"26","author":"Moorthy","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.apha.2026.02.006_bib61","article-title":"TRAIL-receptor","author":"Moorthy","year":"2021","journal-title":"Agonists for the Treatment of Glioblastoma"},{"issue":"14","key":"10.1016\/bs.apha.2026.02.006_bib62","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1039\/C7OB00220C","article-title":"Optimisation of the dibromomaleimide (DBM) platform for native antibody conjugation by accelerated post-conjugation hydrolysis","volume":"15","author":"Morais","year":"2017","journal-title":"Organic and Biomolecular Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82037-2","article-title":"Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody","volume":"11","author":"Morito","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2026.02.006_bib64","unstructured":"Naldini, L.,\u00a0Blomer,\u00a0U.,\u00a0Gage,\u00a0F.H.,\u00a0Tronot,\u00a0D.,\u00a0Verma,\u00a0I.M. (1996).\u00a0Genetic engineering of viruses and of vrus vectors. 93."},{"issue":"4","key":"10.1016\/bs.apha.2026.02.006_bib65","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/bs.apha.2026.02.006_bib66","series-title":"Trends in biotechnology","first-page":"36","article-title":"Antibody approaches to treat brain diseases","author":"Neves","year":"2016"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.006_bib67","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1007\/s11095-016-2015-0","article-title":"Anti-cancer antibody trastuzumab-melanotransferrin conjugate (BT2111) for the treatment of metastatic HER2+ breast cancer tumors in the brain: An in-vivo study","volume":"33","author":"Nounou","year":"2016","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/anie.201508445","article-title":"MiniAp-4: A venom-inspired peptidomimetic for brain delivery","volume":"55","author":"Oller-Salvia","year":"2016","journal-title":"Angewandte Chemie - International Edition"},{"key":"10.1016\/bs.apha.2026.02.006_bib69","series-title":"Chemical society reviews","first-page":"4690","article-title":"Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery","author":"Oller-Salvia","year":"2016"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib70","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/mp400624v","article-title":"Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide","volume":"11","author":"On","year":"2014","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.04.016","article-title":"Local delivery of chondroitinase ABC with or without stromal cell-derived factor 1\u03b1 promotes functional repair in the injured rat spinal cord","volume":"134","author":"Pakulska","year":"2017","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.006_bib72","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2967\/jnumed.118.219576","article-title":"Biodistribution and dosimetry of intraventricularly administered 124I-omburtamab in patients with metastatic leptomeningeal tumors","volume":"60","author":"Pandit-Taskar","year":"2019","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx: the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1227816","article-title":"Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier","volume":"3","author":"Pardridge","year":"2023","journal-title":"Frontiers in Drug Delivery"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","article-title":"Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo","volume":"259","author":"Pardridge","year":"1991","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.006_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","article-title":"Human blood-brain barrier insulin receptor","volume":"44","author":"Pardridge","year":"1985","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","article-title":"Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model","volume":"163","author":"Park","year":"2012","journal-title":"Journal of Controlled Release"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.006_bib78","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as pharmacological carriers to the brain: Promises, shortcomings and challenges","volume":"19","author":"Parrasia","year":"2022","journal-title":"Molecular Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.006_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01307-17","article-title":"Effects of HIV-1 Tat and methamphetamine on blood-brain barrier integrity and function in vitro","volume":"61","author":"Patel","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"13","key":"10.1016\/bs.apha.2026.02.006_bib80","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier","volume":"54","author":"Prades","year":"2015","journal-title":"Angewandte Chemie - International Edition"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.006_bib81","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1039\/D4OB01157K","article-title":"The effects of buffer, pH, and temperature upon SPAAC reaction rates","volume":"23","author":"Pringle","year":"2025","journal-title":"Organic and Biomolecular Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/1535-7163.MCT-14-0399","article-title":"ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice","volume":"14","author":"Regina","year":"2015","journal-title":"Molecular Cancer Therapeutics"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.006_bib83","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1023\/A:1011936007457","article-title":"Antibodies as carrier proteins","author":"Rehlaender","year":"1998","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/bs.apha.2026.02.006_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer\u2019s disease","volume":"203","author":"Rotman","year":"2015","journal-title":"Journal of Controlled Release"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11090481","article-title":"Validation of cadherin HAV6 peptide in the transient modulation of the blood-brain barrier for the treatment of brain tumors","volume":"11","author":"Sajesh","year":"2019","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156452","article-title":"Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders","volume":"11","author":"Salvalaio","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2026.02.006_bib87","series-title":"Advanced in Pharmacology: Brain Peptide Shuttles","article-title":"Polymeric nanoparticles","volume":"Vol. 105","author":"S\u00e1nchez-L\u00f3pez","year":"2025"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091874","article-title":"Peptide shuttles for blood\u2013brain barrier drug delivery","volume":"14","author":"S\u00e1nchez-Navarro","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.006_bib89","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.accounts.7b00204","article-title":"Jumping hurdles: Peptides able to overcome biological barriers","volume":"50","author":"S\u00e1nchez-Navarro","year":"2017","journal-title":"Accounts of Chemical Research"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.006_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028881","article-title":"A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain","volume":"6","author":"Sarkar","year":"2011","journal-title":"PLoS One"},{"issue":"5433","key":"10.1016\/bs.apha.2026.02.006_bib91","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: Delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science (New York, N. Y.)"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.006_bib92","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1021\/acsnano.9b01515","article-title":"Targeting ligands deliver model drug cargo into the central nervous system along autonomic neurons","volume":"13","author":"Sellers","year":"2019","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib93","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1096\/fj.07-9357com","article-title":"Inhibition of \u03b3\u2010secretase causes increased secretion of amyloid precursor protein C\u2010terminal fragments in association with exosomes","volume":"22","author":"Sharples","year":"2008","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2026.02.006_bib94","doi-asserted-by":"crossref","unstructured":"Shen, W.-C. , & Ryser, J.-P. (1978). Cell biology conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins (membrane transport of macromolecules\/cationized enzyme\/pinocytosis) (Vol. 75, Issue 4).","DOI":"10.1073\/pnas.75.4.1872"},{"issue":"11","key":"10.1016\/bs.apha.2026.02.006_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112425","article-title":"Protein and gene delivery systems for neurodegenerative disorders: Where do we stand today?","volume":"14","author":"Siafaka","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12010-012-9962-7","article-title":"Recombinant single-chain antibody with the trojan peptide penetratin positioned in the linker region enables cargo transfer across the blood-brain barrier","volume":"169","author":"\u0160krlj","year":"2013","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib97","doi-asserted-by":"crossref","first-page":"226","DOI":"10.14348\/molcells.2014.2314","article-title":"Tat-fused recombinant human SAG prevents dopaminergic neurodegeneration in a MPTP-induced Parkinson\u2019s disease model","volume":"37","author":"Sohn","year":"2014","journal-title":"Molecules and Cells"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/emmm.201202083","article-title":"A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA","volume":"5","author":"Sorrentino","year":"2013","journal-title":"EMBO Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016575","article-title":"Peripheral delivery of a CNS targeted, metalo-protease reduces A\u03b2 toxicity in a mouse model of alzheimer\u2019s disease","volume":"6","author":"Spencer","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/bs.apha.2026.02.006_bib100","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2026.02.006_bib101","doi-asserted-by":"crossref","unstructured":"Sun, Z., Huang, J., Fishelson, Z., Wang, C., & Zhang, S. (2023). Cell-penetrating peptidebased delivery of macromolecular drugs: Development, strategies, and progress. Multidisciplinary Digital Publishing Institute (MDPI). Biomedicines, 11(7), https:\/\/doi.org\/10.3390\/biomedicines11071971.","DOI":"10.3390\/biomedicines11071971"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib102","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/acs.molpharmaceut.5b00607","article-title":"Brain delivery of drug and MRI contrast agent: Detection and quantitative determination of brain deposition of CPT-Glu using LC-MS\/MS and Gd-DTPA using magnetic resonance imaging","volume":"13","author":"Tabanor","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"10","key":"10.1016\/bs.apha.2026.02.006_bib103","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model","volume":"39","author":"Thom","year":"2019","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.apha.2026.02.006_bib104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2015.07.007","article-title":"The \u201cfate\u201d of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood-brain barrier crossing and trafficking into the central nervous system","volume":"32","author":"Tosi","year":"2016","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"10.1016\/bs.apha.2026.02.006_bib106","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1021\/acs.molpharmaceut.9b00763","article-title":"In vivo brain delivery and brain deposition of proteins with various sizes","volume":"16","author":"Ulapane","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1163","article-title":"Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice","volume":"12","author":"Ullman","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"9","key":"10.1016\/bs.apha.2026.02.006_bib108","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/cbic.201100206","article-title":"Protein modification by strain-promoted alkyne-azide cycloaddition","volume":"12","author":"Van Hest","year":"2011","journal-title":"Chembiochem: a European Journal of Chemical Biology"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib109","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"Journal of Controlled Release"},{"issue":"October","key":"10.1016\/bs.apha.2026.02.006_bib110","first-page":"1","article-title":"The discovery of insulin: An important milestone in the history of medicine","volume":"9","author":"Vecchio","year":"2018","journal-title":"Frontiers in Endocrinology"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020173","article-title":"Focus on extracellular vesicles: Exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"17","author":"Vella","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib112","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/path.2145","article-title":"Packaging of prions into exosomes is associated with a novel pathway of PrP processing","volume":"211","author":"Vella","year":"2007","journal-title":"Journal of Pathology"},{"key":"10.1016\/bs.apha.2026.02.006_bib113","doi-asserted-by":"crossref","unstructured":"Viv\u00e8s, E., Brodin, P., & Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus\u204e.","DOI":"10.1074\/jbc.272.25.16010"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib114","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.taap.2014.03.005","article-title":"Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: Safety, pharmacokinetics, and distribution","volume":"277","author":"Vuillemenot","year":"2014","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2026.02.006_bib115","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/hmg\/ddr554","article-title":"A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich\u2019s ataxia mouse model","volume":"21","author":"Vyas","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib116","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nature Medicine"},{"issue":"42","key":"10.1016\/bs.apha.2026.02.006_bib117","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1039\/D0SC05128D","article-title":"One-pot thiol-amine bioconjugation to maleimides: Simultaneous stabilisation and dual functionalisation","volume":"11","author":"Wall","year":"2020","journal-title":"Chemical Science"},{"issue":"8","key":"10.1016\/bs.apha.2026.02.006_bib118","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"10.1016\/bs.apha.2026.02.006_bib119","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.7150\/thno.26717","article-title":"Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair","volume":"8","author":"Wang","year":"2018","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/bs.apha.2026.02.006_bib120","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/mp300495e","article-title":"Diffusion of macromolecules in the brain: Implications for drug delivery","volume":"10","author":"Wolak","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.apha.2026.02.006_bib121","first-page":"159","article-title":"Nanoparticle-siRNA: A potential cancer therapy?","volume":"98","author":"Young","year":"2016"},{"issue":"3","key":"10.1016\/bs.apha.2026.02.006_bib122","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids and Barriers of the CNS"},{"issue":"2","key":"10.1016\/bs.apha.2026.02.006_bib124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12975-010-0019-3","article-title":"Enhanced delivery of erythropoietin across the blood-brain barrier for neuroprotection against ischemic neuronal injury","volume":"1","author":"Zhang","year":"2010","journal-title":"Translational Stroke Research"},{"issue":"1","key":"10.1016\/bs.apha.2026.02.006_bib125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron"}],"container-title":["Advances in Pharmacology","Brain Shuttle Peptides: Development and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358926000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:58:09Z","timestamp":1780757889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358926000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443415470"],"references-count":125,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2026.02.006","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}